Evidence map›Paper›PMID 24088676›Full record

ArticleAIDS (London, England)2013

HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods.

Lynn T Matthews, Angela Kaida, Steven Kanters, Helen Byakwagamd, A Rain Mocello, Conrad Muzoora, Annet Kembabazi, Jessica E Haberer, Jeffrey N Martin, David R Bangsberg and 1 more

Abstract read
In one paragraph

Article in AIDS (London, England), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Epidemiologic and clinical characteristics ofFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lynn T MatthewsaDivision of Infectious Disease, Massachusetts General Hospital, Center for Global Health bDivision of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts cSimon Fraser University, Faculty of Health Sciences, Burnaby, Canada dDepartment of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California eUniversity of British Columbia, School of Population and Public Health, Vancouver, Canada fMbarara University of Science and Technology, Mbarara, Uganda gDepartment of Medicine, Massachusetts General Hospital, Center for Global Health, Boston, Massachusetts hUniversity of California at San Francisco, Department of Medicine, San Francisco, California, USA.
Angela Kaida
Steven Kanters
Helen Byakwagamd
A Rain Mocello
Conrad Muzoora
Annet Kembabazi
Jessica E Haberer
Jeffrey N Martin
David R Bangsberg
Peter W Hunt

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
TB PREVENTION AND HIV IN THE HOMELESS--AN INTERVENTIONR01MH054907 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BANGSBERG, DAVID ROY · 1995 to 2014
$20.7M
Novel Measures and Theory of Pediatric Antiretroviral Therapy Adherence in UgandaK23MH087228 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI HABERER, JESSICA ELIZABETH · 2009 to 2013
$916k
Periconception HIV risk reduction for HIV-discordant couples in UgandaK23MH095655 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI MATTHEWS, LYNN T · 2011 to 2015
$854k
Mentoring Patient Oriented Adherence Research in UgandaK24MH087227 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BANGSBERG, DAVID ROY · 2009 to 2013
$776k
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected AfricansR56AI100765 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUNT, PETER W · 2012 to 2012
$450k
Fertility desire and pregnancy in a cohort of discordant Ugandan couples on ARTR21HD069194 · NICHD · SIMON FRASER UNIVERSITY · PI KAIDA, ANGELA KANANA · 2011 to 2012
$303k
NIAID NIH HHS AI100765NIAID NIH HHS P30 AI027763NIAID NIH HHS R56 AI100765NICHD NIH HHS HD069194NICHD NIH HHS R21 HD069194NIMH NIH HHS K23 MH087228NIMH NIH HHS K23 MH095655NIMH NIH HHS K24 MH087227NIMH NIH HHS MH54907NIMH NIH HHS R01 MH054907PHS HHS 087228PHS HHS NIAID P30 027763PHS HHS NIMH 095655PHS HHS NIMH 87227
6 · The paper itself

Abstract

objectiveTo assess the impact of pregnancy on mortality among HIV-infected Ugandan women initiating ART.

designProspective cohort study.

methodsHIV-infected women initiating ART in the Uganda AIDS Rural Treatment Outcomes study were assessed quarterly for self-reported pregnancy. The association between pregnancy and postpartum ('pregnancy-related') follow-up periods and mortality was assessed with Cox proportional hazards models adjusted for age, CD4 cell count, plasma HIV-1 RNA levels, and ART duration.

resultsThree hundred and fifty-four women with median age 33 years (IQR: 27-37) and CD4 142 cells/μl (IQR: 82-213) were followed for a median of 4.0 years (IQR: 2.5-4.8) after ART initiation, with 3 and 7% loss-to-follow-up at years 1 and 5. One hundred and nine women experienced pregnancy. Five deaths occurred during pregnancy-related follow-up and 16 during nonpregnancy-related follow-up, for crude mortality rates during the first year after ART initiation of 12.57/100 PYs and 3.53/100 PYs (rate ratio 3.56, 95% CI: 0.97-11.07). In adjusted models, the impact of pregnancy-related follow-up on mortality was highest at ART initiation (aHR: 21.48, 95% CI: 3.73-123.51), decreasing to 13.44 (95% CI 3.28-55.11) after 4 months, 8.28 (95% CI 2.38-28.88) after 8 months, 5.18 (95% CI: 1.36-19.71) after 1 year, and 1.25 (95% CI: 0.10-15.58) after 2 years on ART. Four of five maternal deaths occurred postpartum.

conclusionPregnancy and the postpartum period were associated with increased mortality in HIV-infected women initiating ART, particularly during early ART. Contraception proximate to ART initiation, earlier ART initiation, and careful monitoring during the postpartum period may reduce maternal mortality in this setting.

Indexed as

Postpartum PeriodAdultAnti-Retroviral AgentsCD4 Lymphocyte CountCohort StudiesFemaleHIV-1HIV InfectionsHumansPregnancyPregnancy Complications, InfectiousProspective StudiesRNA, ViralSurvival AnalysisUgandaViral LoadAnti-Retroviral AgentsRNA, Viral

Identifiers

PMID24088676
PMCPMC4142689

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.